HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized study.

AbstractOBJECTIVE:
Vitamin D insufficiency is common in primary hyperparathyroidism (pHPT). Patients with pHPT frequently have a reduced health-related quality of life (HRQoL). Our objectives were to evaluate whether HRQoL in pHPT is associated with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy (PTX) could improve HRQoL.
DESIGN:
A randomized, double-blind study (ClinicalTrials.gov identifier: NCT00982722).
METHODS:
The study included 150 pHPT patients randomized, 6 weeks after PTX, to daily treatment with either cholecalciferol 1600 IU and calcium carbonate 1000 mg (D+) or calcium carbonate alone (D-). HRQoL was estimated with SF-36 before and after PTX and after 12 months of study medication.
RESULTS:
Three-quarters (77%) of the pHPT patients had vitamin D insufficiency, defined as 25OHD <50 nmol/l. The pHPT patients scored lower than a reference population in all domains of SF-36. A total of 135 patients completed the entire study period. Improvements in nearly all domains were registered at the follow-up 6 weeks after PTX. At the end of the study medication period, the D+ group had a significantly higher median serum (s-) 25OHD concentration (76 (65; 93) (lower; upper interquartile ranges) vs 48 (40; 62) nmol/l, P<0.001) and a lower plasma (p-) parathyroid hormone concentration (40 (34; 52) vs 49 (38; 66) ng/l, P=0.01) than the D- group. The improvements in HRQoL remained unchanged at the follow-up 1 year after PTX. Postoperative vitamin D supplementation had no obvious effect on HRQoL.
CONCLUSION:
PTX resulted in significant improvements in HRQoL. Despite a high prevalence of vitamin D insufficiency, 1 year of postoperative vitamin D supplementation had no obvious beneficial effect on HRQoL.
AuthorsViveca Åberg, Sophie Norenstedt, Jan Zedenius, Maria Sääf, Jörgen Nordenström, Ylva Pernow, Inga-Lena Nilsson
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 172 Issue 2 Pg. 181-7 (Feb 2015) ISSN: 1479-683X [Electronic] England
PMID25414430 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2015 The authors.
Chemical References
  • Vitamin D
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Dietary Supplements
  • Double-Blind Method
  • Female
  • Health Surveys (methods)
  • Humans
  • Hyperparathyroidism, Primary (diagnosis, drug therapy, surgery)
  • Male
  • Middle Aged
  • Postoperative Care (methods)
  • Quality of Life
  • Treatment Outcome
  • Vitamin D (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: